News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,528 Results
Type
Article (42604)
Company Profile (308)
Press Release (647616)
Section
Business (205165)
Career Advice (2003)
Deals (35495)
Drug Delivery (85)
Drug Development (81374)
Employer Resources (169)
FDA (16175)
Job Trends (14894)
News (346661)
Policy (32678)
Tag
Academia (2611)
Alliances (49521)
Alzheimer's disease (1210)
Approvals (16089)
Artificial intelligence (113)
Bankruptcy (355)
Best Places to Work (11536)
Biotechnology (224)
Breast cancer (99)
Cancer (869)
Career advice (1670)
Cell therapy (194)
Clinical research (64215)
Collaboration (318)
Compensation (157)
COVID-19 (2556)
Cystic fibrosis (78)
Data (809)
Diabetes (125)
Diagnostics (6156)
Drug pricing (77)
Earnings (84286)
Employer resources (146)
Events (109583)
Executive appointments (237)
FDA (16596)
Funding (278)
Gene therapy (156)
GLP-1 (557)
Government (4347)
Healthcare (18765)
Infectious disease (2626)
Inflammatory bowel disease (101)
Interviews (313)
IPO (16321)
Job creations (3646)
Job search strategy (1429)
Layoffs (414)
Legal (7901)
Lung cancer (153)
Manufacturing (145)
Medical device (13146)
Medtech (13151)
Mergers & acquisitions (19166)
Metabolic disorders (346)
Neuroscience (1446)
NextGen Class of 2024 (6565)
Non-profit (4528)
Northern California (1142)
Obesity (208)
Opinion (180)
Patents (95)
People (56514)
Phase I (19973)
Phase II (28255)
Phase III (21095)
Pipeline (195)
Postmarket research (2574)
Preclinical (8544)
Radiopharmaceuticals (235)
Rare diseases (185)
Real estate (5927)
Regulatory (21595)
Research institute (2407)
Resumes & cover letters (351)
Southern California (1046)
Startups (3616)
United States (11276)
Vaccines (540)
Weight loss (154)
Date
Today (242)
Last 7 days (805)
Last 30 days (2852)
Last 365 days (36323)
2024 (30032)
2023 (40330)
2022 (51535)
2021 (56047)
2020 (54412)
2019 (46880)
2018 (35302)
2017 (32462)
2016 (31922)
2015 (37930)
2014 (31656)
2013 (26850)
2012 (29031)
2011 (29673)
2010 (27749)
Location
Africa (738)
Arizona (186)
Asia (37492)
Australia (6156)
California (2620)
Canada (1143)
China (204)
Colorado (112)
Connecticut (116)
Europe (80800)
Florida (373)
Georgia (94)
Illinois (303)
Indiana (176)
Kansas (95)
Maryland (501)
Massachusetts (2136)
Michigan (142)
Minnesota (244)
New Jersey (793)
New York (803)
North Carolina (663)
Northern California (1142)
Ohio (123)
Pennsylvania (736)
South America (1113)
Southern California (1046)
Texas (363)
Utah (76)
Washington State (315)
690,528 Results for "decode genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
deCODE genetics: A sequence variant that increases risk of pregnancy loss
Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study in Nature Structural & Molecular Biology titled “Variant in the synaptonemal complex protein SYCE2 associates with pregnancy loss through effects on recombination”.
January 29, 2024
·
2 min read
Press Releases
clock.bio Raises $5.3M Seed Funding and Decodes Genetic Atlas of Human Rejuvenation Factors
October 9, 2024
·
3 min read
Press Releases
deCODE genetics: Variants in the genome affect DNA methylation
July 24, 2024
·
2 min read
BioMidwest
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
Recursion, a leading clinical stage TechBio company decoding biology to industrialize drug discovery, published in Nature Genetics scientific findings that highlights a potential limitation of CRISPR-Cas9 in gene editing - a key component in understanding disease mechanisms, and developing new therapeutic approaches.
May 29, 2024
·
5 min read
Business
Breakthrough in Brain–Computer Interface Technology: A New Era of Neural Decoding at the Society for Neuroscience Annual Meeting, Neuroscience 2024
October 7, 2024
·
4 min read
Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Genetics in Medicine, an official journal of the American College of Medical Genetics and Genomics (ACMG), published a new study validating RiskScore®, Myriad’s breast cancer risk assessment tool integrated into its MyRisk® Hereditary Cancer Test.
June 3, 2024
·
4 min read
Press Releases
Inagene Diagnostics Inc. Launches Canada’s Most Comprehensive Genetic Test for Cardiovascular Medications, Highlighting Major Gaps in Heart Medication Awareness
October 25, 2024
·
3 min read
Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition
A comprehensive new study from deCODE genetics, a subsidiary of Amgen, published today in Nature Genetics, provides insights into the epidemiology and somatic and germline genetics of clonal hematopoiesis.
November 6, 2023
·
4 min read
BioMidwest
Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen
Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced the addition of a new Universal Plus Panel to its Foresight® Carrier Screen.
June 4, 2024
·
2 min read
Biotech Beach
Ionis to present at TD Cowen Genetic Medicines & RNA Summit
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a fireside chat at the virtual TD Cowen Genetic Medicines & RNA Summit on Thursday, June 20, 2024.
June 17, 2024
·
1 min read
1 of 69,053
Next